• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION, INC CHLORAPREP ONE STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION, INC CHLORAPREP ONE STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number 270400
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 02/26/2021
Event Type  Injury  
Manufacturer Narrative
(b)(6) initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).
 
Event Description
Material no.: 270400.Batch no.: 0274685.It was reported the patient experienced dryness and redness on skin using chloraprep.This initial report is being reported by lpch on behalf of the patient's husband.A [omitted] patient with [omitted] started using chlorprep alongside her medication for pulmonary hypertension in 2010.Batch number and expiry date- 0274685 (30/09/23).On (b)(6) 2021 the patient's husband reported the patient is experiencing dryness and redness on her skin where she applies chloroprep.At the time of the report the outcome of the event was unknown.The patient's husband considered the event as "reported causality" to chloroprep.No medical history available.The patient takes veletri.No other medications taken by the patient are known.No further information was provided.The patient was taking chloroprep for: pulmonary hypertension.
 
Event Description
Material no.: 270400 batch no.: 0274685 it was reported the patient experienced dryness and redness on skin using chloraprep.This initial report is being reported by lpch on behalf of the patient's husband.A [omitted] patient with [omitted] started using chlorprep alongside her medication for pulmonary hypertension in 2010.Batch number and expiry date- 0274685 (30/09/23).On (b)(6) 2021 the patient's husband reported the patient is experiencing dryness and redness on her skin where she applies chloroprep.At the time of the report the outcome of the event was unknown.The patient's husband considered the event as "reported causality" to chloroprep.No medical history available.The patient takes veletri.No other medications taken by the patient are known.The patient was taking chloroprep for: pulmonary hypertension..
 
Manufacturer Narrative
Chloraprep (b)(6) lot number 0263751 was reviewed and no non-conformities, failures, deviations, or rework activities occurred during the formulation of this lot.No photograph or sample was received for analysis; therefore, the failure mode could not be confirmed, nor could the root cause be determined.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Follow up emdr (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP ONE STEP
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION, INC
75 n. fairview drive
vernon hills IL 60061
MDR Report Key11558892
MDR Text Key257139047
Report Number3004932373-2021-00144
Device Sequence Number1
Product Code KXF
Combination Product (y/n)Y
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,other
Type of Report Initial,Followup
Report Date 08/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Catalogue Number270400
Device Lot Number0274685
Initial Date Manufacturer Received 03/09/2021
Initial Date FDA Received03/23/2021
Supplement Dates Manufacturer Received08/23/2021
Supplement Dates FDA Received08/23/2021
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age49 YR
-
-